Search / Trial NCT02383342

Pain Predict Genetics
Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Mar 6, 2015

Download PDF

Apply for Trial

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Clinical Predictors Genetic Factors

ClinConnect Summary

The Pain Predict Genetics trial is a research study aimed at understanding how our genes might affect our experience of pain after surgery. Researchers believe that certain genetic factors could help predict whether someone will develop acute (short-term) or chronic (long-term) pain after undergoing major surgery. By identifying these genetic markers, the goal is to improve how healthcare providers can tailor pain management and treatment for individual patients.

To participate in this study, you must be between 18 and 80 years old and scheduled for elective (planned) surgery. If you decide to join, you'll be asked to fill out some questionnaires about your health and pain. This is a great opportunity to contribute to important research that could help improve pain care for future patients. The study is currently looking for volunteers, and all genders are welcome to participate.

Gender

ALL

Eligibility criteria

Inclusion Criteria:
Patients:
• Ages 18 - 80 years, consenting, planned surgery, able to understand and answer questionnaires.
Exclusion Criteria:
• Non-consent, inability to give consent, unplanned and emergency surgery.

About Radboud University Medical Center

Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.

Locations

Nijmegen, , Netherlands

Patients applied

0 patients applied

Trial Officials

Han G Brunner, Prof. PhD.

Study Director